Anika Reports Third Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Anika Therapeutics (ANIK) Tops Q3 EPS by 25c
October 24, 2019 4:36 PM EDTAnika Therapeutics (NASDAQ: ANIK) reported Q3 EPS of $0.64, $0.25 better than the analyst estimate of $0.39. Revenue for the quarter came in at $29.7 million versus the consensus estimate of $27.01 million.
Anika delivered double-digit revenue and earnings growth in the third quarter on the strength of growing global demand, Anikas expanding commercial platform, and... More



